# Integrative Multi-Omics and Machine Learning Identify ID1 as a Candidate Gene Associated with Abdominal Aortic Aneurysm

**Authors:** Feng Guo, Michael Keese, Yu Zhao, Qining Fu

PMC · DOI: 10.3390/cimb48020156 · 2026-01-30

## TL;DR

This study uses multi-omics and machine learning to identify ID1 as a gene linked to abdominal aortic aneurysm, suggesting its role in immune and matrix changes.

## Contribution

ID1 is newly identified as a candidate gene associated with AAA through integrative multi-omics and machine learning analysis.

## Key findings

- ID1 is consistently downregulated in AAA across multiple datasets and shows strong discriminatory ability (AUC = 0.939 and 0.868).
- Low ID1 expression correlates with immune cell changes like increased M1 macrophages and γδ T cells in AAA.
- Single-cell RNA sequencing confirms ID1 downregulation in endothelial and fibroblast cells in AAA.

## Abstract

Abdominal aortic aneurysm (AAA) is a fatal vascular disorder driven by immune dysregulation and extracellular matrix (ECM) degradation, yet its molecular mechanisms remain unclear. This study investigated the mechanistic role of ID1 in AAA using an integrative multi-omics and machine learning approach. Two bulk transcriptomic datasets (GSE232911 and GSE183464) were analyzed through differential expression, WGCNA, and three machine learning algorithms (LASSO, Random Forest, and SVM-RFE), followed by immune infiltration analysis via ssGSEA and CIBERSORT. ID1 and CYP4B1 were identified by all three machine learning algorithms, but only ID1 showed stable downregulation and consistent discriminatory ability across independent datasets. (AUC = 0.939 and 0.868). Functional enrichment and immune deconvolution linked low ID1 expression to enhanced adaptive immune signaling, increased M1 macrophages, γδ T cells, and memory B cells, and reduced neutrophil and mast cell activity. Single-cell RNA sequencing (GSE226492) confirmed endothelial- and fibroblast-specific ID1 downregulation in AAA. These findings identify ID1 as a candidate gene associated with vascular immune remodeling and extracellular matrix–related pathways, providing a basis for future mechanistic investigation in AAA.

## Linked entities

- **Genes:** ID1 (inhibitor of DNA binding 1) [NCBI Gene 3397], CYP4B1 (cytochrome P450 family 4 subfamily B member 1) [NCBI Gene 1580]
- **Diseases:** abdominal aortic aneurysm (MONDO:0005350)

## Full-text entities

- **Genes:** CD8A (CD8 subunit alpha) [NCBI Gene 925] {aka CD8, CD8alpha, IMD116, Leu2, p32}, VCAM1 (vascular cell adhesion molecule 1) [NCBI Gene 7412] {aka CD106, INCAM-100}, TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, CYP4B1 (cytochrome P450 family 4 subfamily B member 1) [NCBI Gene 1580] {aka CYPIVB1, P-450HP}, DCLRE1B (DNA cross-link repair 1B) [NCBI Gene 64858] {aka APOLLO, DKCB8, SNM1B, SNMIB}, PRODH (proline dehydrogenase 1) [NCBI Gene 5625] {aka HSPOX2, PIG6, POX, PRODH1, TP53I6}, KDM6B (lysine demethylase 6B) [NCBI Gene 23135] {aka JMJD3, NEDCFSA, NEDSST}, INMT (indolethylamine N-methyltransferase) [NCBI Gene 11185] {aka TEMT}, LPIN3 (lipin 3) [NCBI Gene 64900] {aka LIPN3L, SMP2, dJ620E11.2}, CXCL2 (C-X-C motif chemokine ligand 2) [NCBI Gene 2920] {aka CINC-2a, GRO2, GROb, MGSA-b, MIP-2a, MIP2}, AAA1 (aortic aneurysm, familial abdominal 1) [NCBI Gene 100329167] {aka AAA}, CDV3 (CDV3 homolog) [NCBI Gene 55573] {aka H41}, KIF1C (kinesin family member 1C) [NCBI Gene 10749] {aka LTXS1, SATX2, SAX2, SPAX2, SPG58}, HLA-A (major histocompatibility complex, class I, A) [NCBI Gene 3105] {aka HLAA}, CD4 (CD4 molecule) [NCBI Gene 920] {aka CD4mut, IMD79, Leu-3, OKT4D, T4}, BMP1 (bone morphogenetic protein 1) [NCBI Gene 649] {aka OI13, PCOLC, PCP, TLD}, VDR (vitamin D receptor) [NCBI Gene 7421] {aka NR1I1, PPP1R163}, CTTN (cortactin) [NCBI Gene 2017] {aka EMS1}, GPR132 (G protein-coupled receptor 132) [NCBI Gene 29933] {aka G2A}, ROR2 (ROR family WNT receptor 2) [NCBI Gene 4920] {aka BDB, BDB1, NTRKR2, RRS1}, NPR1 (natriuretic peptide receptor 1) [NCBI Gene 4881] {aka ANP-A, ANPRA, ANPa, GC-A, GUC2A, GUCY2A}, ID1 (inhibitor of DNA binding 1) [NCBI Gene 3397] {aka ID, bHLHb24}, VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422] {aka L-VEGF, MVCD1, VEGF, VPF}, SLC45A1 (solute carrier family 45 member 1) [NCBI Gene 50651] {aka DNB5, IDDNPF, PAST-A}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, ERBB2 (erb-b2 receptor tyrosine kinase 2) [NCBI Gene 2064] {aka CD340, HER-2, HER-2/neu, HER2, MLN 19, MLN-19}, ID3 (inhibitor of DNA binding 3) [NCBI Gene 3399] {aka HEIR-1, bHLHb25}, LAMB2 (laminin subunit beta 2) [NCBI Gene 3913] {aka LAMS, NPHS5, PIERS}, TNFAIP3 (TNF alpha induced protein 3) [NCBI Gene 7128] {aka A20, AIFBL1, AISBL, OTUD7C, TNFA1P2}, PHLDA1 (pleckstrin homology like domain family A member 1) [NCBI Gene 22822] {aka DT1P1B11, PHRIP, TDAG51}, ICAM1 (intercellular adhesion molecule 1) [NCBI Gene 3383] {aka BB2, CD54, P3.58}
- **Diseases:** dilation of the (MESH:D002311), vascular disorder (MESH:D002561), AAA (MESH:D017544), thrombus (MESH:D013927), microvascular injury (MESH:D017566), ID3 deficiency (MESH:D007153), hypertension (MESH:D006973), atherosclerosis (MESH:D050197), immune dysregulation (OMIM:614878), Staphylococcus aureus infection (MESH:D013203), pulmonary hypertension (MESH:D006976), Tuberculosis (MESH:D014376), aneurysm (MESH:D000783), rupture (MESH:D012421), aorta (MESH:D000784), endothelial dysfunction (MESH:D014652), inflammation (MESH:D007249), degenerative (MESH:D019636), injury to (MESH:D014947), vascular rarefaction (MESH:D000073436), fibrosis (MESH:D005355), hemorrhage (MESH:D006470)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

9 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12939636/full.md

---
Source: https://tomesphere.com/paper/PMC12939636